A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.

Abstract

PURPOSE This study was designed to evaluate the effect of chitosan-N-acetylcysteine (C-NAC) eye drops on tear film thickness (TFT) in patients with dry eye syndrome (DES). METHODS This was a controlled, randomized, double-blind clinical investigation with patients assigned to 2 cohorts. In Cohort I, 21 patients were randomized to receive 1 instillation of… (More)
DOI: 10.1089/jop.2016.0123

Topics

Cite this paper

@article{Schmidl2017ACR, title={A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.}, author={Doreen Schmidl and Ren{\'e} Marcel Werkmeister and Semira Kaya and Angelika Unterhuber and Katarzyna Witkowska and Renate R. Baumgartner and Sonja H{\"{o}ller and M O'rourke and Ward D. Peterson and Annika Wolter and Martin Prinz and Leopold Schmetterer and Gerhard Garh{\"{o}fer}, journal={Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics}, year={2017}, volume={33 5}, pages={375-382} }